Forest Labs Picks Board Member As New CEO; Shares Rise
September 10, 2013 at 11:23 AM EDT
The struggle by Forest Laboratories (FRX) to deal with the loss of market exclusivity for major drugs, including its antidepressant Lexapro, now rests on the shoulders of a former Bausch & Lomb chief executive. On Tuesday morning, Forest named Brenton L. Saunders, 43, as its new CEO, effective Oct. 1. He will replace retiring head [...]
